Michael Bollong and his team discovered a way to restore lung stem cells’ regenerative capacity and a potential drug for idiopathic pulmonary fibrosis.
Injecting lung stem cells into the bloodstream of mice with idiopathic pulmonary fibrosis improved their lung function, setting the stage for human trials.
After a heart attack, the damage is permanent — for now. Researchers are testing innovative ways to get the heart to regenerate muscle cells and fix itself.